Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
08/10/2000 | WO2000045830A1 Materials for preventing arteriosclerosis, immunopotentiating materials, vertebrates fed with these materials and eggs thereof |
08/10/2000 | WO2000045824A1 Preventive and therapeutic agents for arteriosclerosis |
08/10/2000 | WO2000045820A1 Use of moxonidine for postmyocardial infarction treatment |
08/10/2000 | WO2000045819A1 Use of cholesterol-lowering agent |
08/10/2000 | WO2000045817A1 Drug combinations comprising (e) -7 - [4 -(4 -fluorophenyl) -6 - isopropyl -2 - [methyl (methylsulfonyl) amino] pyrimidin -5 -yl] (3r,5s) -3,5 - dihydroxyhept -6 - enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4 |
08/10/2000 | WO2000045811A1 Method for the prevention or reduction of cariovascular events associated with coronary intervention |
08/10/2000 | WO2000045810A1 Method for the prevention or reduction of cardiovascular events associated with coronary intervention |
08/10/2000 | WO2000045809A1 L-arginine based formulations for treating diseases and methods of using same |
08/10/2000 | WO2000045807A1 Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol |
08/10/2000 | WO2000045806A1 α1-ADRENERGIC RECEPTOR ANTAGONISTS |
08/10/2000 | WO2000045795A2 Topical sprays comprising a film forming composition |
08/10/2000 | WO2000045791A2 Method for controlling liposome size |
08/10/2000 | WO2000045634A1 Inositol derivatives for inhibiting superoxide anion production |
08/10/2000 | WO2000027822A3 Tricyclic pyrazole derivatives |
08/10/2000 | WO2000026399A3 Method for the production of quercetin and isoquercetin derivatives |
08/10/2000 | WO2000026239A3 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
08/10/2000 | WO2000024911A3 Human phospholipases |
08/10/2000 | WO2000021525A3 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
08/10/2000 | WO2000015206A3 Tryptophanyl ester and their n-acyl derivatives for the prevention and treatment of diseases caused or exacerbated by oxidation processes |
08/10/2000 | WO2000013706A8 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor |
08/10/2000 | WO2000013691A9 3-deazaadenosine prevents atherosclerosis and graft vasculopathy |
08/10/2000 | WO2000012118A8 Inhibiting cardiomyocyte death |
08/10/2000 | WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors |
08/10/2000 | DE19906159A1 16-Hydroxyestratriene als selektiv wirksame Estrogene 16-hydroxyestratrienes as selective estrogens effective |
08/10/2000 | DE19904710A1 Substituierte 4-Amino-2-aryl-tetrahydrochinazoline, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical compositions containing them |
08/10/2000 | CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor |
08/10/2000 | CA2361615A1 The use of vascular endothelial growth factor 2 antagonist in the treatment of an injury to or disorder of an eye |
08/10/2000 | CA2361581A1 Method for the prevention or reduction of cariovascular events associated with coronary intervention |
08/10/2000 | CA2361578A1 Method for the prevention or reduction of cardiovascular events associated with coronary intervention |
08/10/2000 | CA2361575A1 L-arginine based formulations for treating diseases and methods of using same |
08/10/2000 | CA2361551A1 Method for controlling liposome size |
08/10/2000 | CA2361066A1 Inositol derivatives for inhibiting superoxide anion production |
08/10/2000 | CA2358855A1 Benzazepine derivatives as alpha-v integrin receptor antagonists |
08/10/2000 | CA2358641A1 Use of cholesterol-lowering agent |
08/10/2000 | CA2357013A1 Anti-inflammatory indole derivatives |
08/10/2000 | CA2321107A1 Materials for preventing arteriosclerosis, immunopotentiating materials, vertebrates fed with these materials and eggs thereof |
08/09/2000 | EP1025853A2 Pharmaceutical composition containing S-nitroso-heme proteins and use thereof |
08/09/2000 | EP1025227A2 Human toll homologues |
08/09/2000 | EP1025216A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
08/09/2000 | EP1025116A1 Estra-1,3,5(10)-triene-7alpha-thioethers |
08/09/2000 | EP1025106A2 Allosteric adenosine receptor modulators |
08/09/2000 | EP1025102A1 Bicyclic kinase inhibitors |
08/09/2000 | EP1025100A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use |
08/09/2000 | EP1025098A1 Benzothiophenes |
08/09/2000 | EP1025096A1 Substituted chroman derivatives |
08/09/2000 | EP1025095A1 Substituted chroman derivatives |
08/09/2000 | EP1025094A1 Substituted indan derivatives |
08/09/2000 | EP1025090A1 Vitronectin receptor antagonists |
08/09/2000 | EP1025086A1 Benzamidine derivatives as factor xa inhibitors |
08/09/2000 | EP1025082A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
08/09/2000 | EP1024825A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity |
08/09/2000 | EP1024819A1 Citrus peel extract as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
08/09/2000 | EP1024813A1 Use of sulfated oligosaccharides as inhibitors of cardiovascular disease |
08/09/2000 | EP1024812A1 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof |
08/09/2000 | EP1024811A1 Novel benzodiazepine derivatives as antiarrhythmic agents |
08/09/2000 | EP1024804A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels |
08/09/2000 | EP1024801A2 Method for regulating size and growth of vascularized normal tissue |
08/09/2000 | EP1024794A1 Methods of treating capsules and dry, powdered pharmaceutical formulations |
08/09/2000 | EP1024793A1 Osmotic medicament releasing system |
08/09/2000 | EP1024696A1 Combination therapy for reducing the risks associated with cardio- and cerebrovascular disease |
08/09/2000 | EP0820434B1 Phenoxyethylamine derivatives having high affinity for the 5-ht 1a receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives |
08/09/2000 | EP0642513B1 Indolocarbazole imides and their use |
08/09/2000 | CN1262681A 4,5-dihydro-[1H]-benz [g] indazole-3-carboxylic acid derivatives |
08/09/2000 | CN1262676A 吡啶衍生物 Pyridine derivatives |
08/09/2000 | CN1262105A Chinese-medicinal oral liquid for treating cerebral diseases caused by hypertension and its preparing process |
08/09/2000 | CN1055215C 银杏酒及其制备方法 Ginkgo wine and its preparation method |
08/09/2000 | CN1055210C Compound tsaoko injection and preparation method thereof |
08/08/2000 | US6101412 Compositions, apparatus and methods for facilitating surgical procedures |
08/08/2000 | US6100297 Administering antioxidant cardioplegic solution during coronary bypass surgery |
08/08/2000 | US6100282 Thiazole derivatives |
08/08/2000 | US6100272 Tetracyclic spiro compounds as 5HT1B receptor antagonists |
08/08/2000 | US6100271 Compounds which mediate intracellular signaling response to abnormal external stimuli characteristic of diseases; antiinflammatory agents, antifibrotic agents, antisclerotic agents, antitumor agents |
08/08/2000 | US6100268 Vasoconstrictive dihydrobenzopyran derivatives |
08/08/2000 | US6100267 Enzyme inhibitor for treatment of neurodegenerative disorders, strokes, traumatic brain injury, cataracts |
08/08/2000 | US6100266 Hydroxamic and carboxylic acid derivatives |
08/08/2000 | US6100252 Specified compounds including methyl 2-butyl-1-((2'-(2-oxo-3h-1,2,3,5-oxathiadiazol-4-yl)biphenyl) methyl)-benzimidazole-7-carboxylate; use to treat circulatory diseases such as hypertensive diseases and heart diseases |
08/08/2000 | US6100242 Gene therapies for enhancing cardiac function |
08/08/2000 | US6100237 Use of des-Aspartate-angiotensin I as an agent for the treatment and prevention of neointima formation, restenosis, and arteriosclerosis |
08/08/2000 | US6100060 Recombinant expression system of polynucleotide encoding a specific amino acid sequence and present in a host cell; for recombinant production of wnt-5b polypeptides important in developmental signal transduction |
08/08/2000 | US6100037 Polynucleotide encoding a cyclic nucleotide phosphodiesterase having a specific amino acid sequence; diagnosis, treatment, and prevention of cancer and immune disorders; anticarcinogenic/antidiabetic/antiarthritic agents |
08/08/2000 | US6099851 Therapeutic uses of leuprolide acetate |
08/08/2000 | US6099832 Transplants for myocardial scars |
08/08/2000 | US6099823 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
08/08/2000 | CA2085796C 3(2h)-pyridazinone derivatives and process for the preparation thereof |
08/08/2000 | CA2018438C Imidazolyl-alkenoic acids |
08/08/2000 | CA2017066C Azaindenes |
08/03/2000 | WO2000045167A2 Non-invasive method for detecting target rna |
08/03/2000 | WO2000044897A1 Method of treating restenosis by antisense targeting of c-myc |
08/03/2000 | WO2000044888A2 Dimethylarginine dimethylaminohydrolases |
08/03/2000 | WO2000044862A1 Process of converting rendered triglyceride oil from marine sources into bland, stable oil |
08/03/2000 | WO2000044763A2 Compositions for treating inflammatory response |
08/03/2000 | WO2000044761A2 Ketolide antibiotics |
08/03/2000 | WO2000044757A1 Hesperitin pro-forms with enhanced bioavailability |
08/03/2000 | WO2000044756A1 Thiazolopyrimidine compounds, process for the preparation of the same and uses thereof |
08/03/2000 | WO2000044755A1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
08/03/2000 | WO2000044753A1 Pirazino(aza)indole derivatives |
08/03/2000 | WO2000044752A1 Triazolo-pyridazine derivatives as ligands for gaba receptors |
08/03/2000 | WO2000044750A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND Iλ-A$g(a) |
08/03/2000 | WO2000044745A1 Carbamate derivatives of diaryl 1,3,4-oxadiazolone |
08/03/2000 | WO2000044740A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |